27.27% of cancers had significantly worse OS predicted by the 475 scSTAR-C3 marker genes upregulated after treatment, while 24.24% of cancers had significantly worse OS predicted by the 163 scSTAR-C2 marker genes downregulated after ATHENA treatment (Figures S6F, G). The gene discussed is C2; the disease is cancer.